As pharmaceutical and biotech companies understand the value of cellular-level insights to further personalize patient care, advancements in genomic laboratory capabilities are growing in interest.
In this recent byline article for Today's Clinical Lab, Q2 Solutions' David Latto shares his expert insights on several noteworthy lab-specific innovations in genomics that can be leveraged to enhance patient-centered clinical trials. David dives deeper into the benefits of single-cell sequencing and more.
Read David's full set of insights here.
